Only in today’s session ENZC could surge but couldn’t recover the $0.0620 mark of Monday. On 3 million volume the stock has managed to grow a bit. This move is a factual cause of the positive market change that most stocks have.
Tomorrow the stock may behave oppositely. Nevertheless, Enzolytics has impressed investors with the newly invented IPF Immune which looks promising in generating enormous revenue while covid-19 has not gone yet.
In the morning session, ENZC grew almost 8% but gradually its growth was cut nearly to 1%. Positive financial results are highly expected due to selling IPF Immune which is widely available in the U.S market.